Print

IMPAACT P1112

NCT02256631

Trial Details:

I Ongoing
National Institute of Allergy and Infectious Diseases (NIAID)
VRC-HIVMAB060-00-AB
HIV-exposed infants who are at increased risk of mother-to-child HIV transmission
RandD/trials/Lists/ClinicalTrialsList
4/1/2018
VRC01 Antibody
20 mg/kg injection in the thigh less than 72 hours after birth 40 mg/kg injection in the thigh less than 72 hours after birth 40 mg/kg injection in the thigh less than 5 days after birth. ThenĀ  20 mg/kg injection in the thigh monthly for at least 6 months